As ‘Medicare for All’ Debate Gains Steam, Many Americans Are On The Fence: Survey

Though support or opposition for “Medicare for All” is dominating the 2020 primary headlines, a large group of Americans is more ambivalent about the proposal, a new survey shows. 

Read More

Medicare to Cover Expensive Cancer Cell Therapies

The U.S. Centers for Medicare and Medicaid Services (CMS) on Wednesday said it has finalized a decision to cover expensive cancer cell therapies sold by Gilead Sciences Inc and Novartis AG.

Read More

California AG Takes On ‘Pay for Delay’ Generic Drug Deals

California’s attorney general touted a legal victory last week against drugmakers who he said made secretive, backroom deals to keep less expensive drugs off the market.

Read More

San Jose Sues CVS, Walgreens and Other Drug Distributors, Manufacturers Over Opioids

San Jose has joined cities across the country in calling out the makers and sellers of prescription painkillers like OxyContin and Percocet for furthering the nation’s opioid epidemic.

Read More

CMS Tees Up Medicare Plan Finder Update

The Centers for Medicare & Medicaid Services (CMS) is planning to launch updates to its Medicare Plan Finder (MPF) this month after a report from a government watchdog flagged significant usability concerns with the tool. 

Read More

Why Drug Companies, Hospitals are Spending Big at State Capitol – and What it Means for You

Drug companies, hospitals and dialysis companies spent millions of dollars in the first half of the year fighting bills that would have hurt their bottom lines, according to lobbying reports filed last week.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square